[Other] [Lancet] Efficacy and safety of co-administered once-weekly cagrilintide 2﹞4 mg with once-weekly semaglutide 2﹞4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

mosa2001 Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-16 13:49
Reward10points

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    90


Daily Top Contributors

Return to the list